-
analyses carried out by the School of Cancer Sciences. This covers all GCLP aspects of the Translational Pharmacology Laboratory, based at the WWCRC, the GTRF based at the Queen Elizabeth University Hospital
-
common and rare human diseases and regenerative medicine and facilitate development of new therapeutics in molecular pharmacology. We have a breadth of expertise in multi-disciplinary integrative biology
-
personnel in vivo to understand the contribution of each TSG to Mesothelioma development. You will develop arrange of contemporary skills that will strengthen your potential to progress into a PhD programme
-
(Research): 1 year full-time; 2 years part-time; IPhD: 5 years full-time; Apply now Overview Overview Our PhD programmes offer training in all aspects of molecular pharmacology and our large internationally
-
, research is vital to advance diagnosis, treatment and prevention. Our strength is in identifying and designing novel therapeutic strategies that will lead to clinical trials. PhD: 3-4 years full-time; 5
-
with pollutants? How do we achieve sustainable animal production whilst protecting animal health and welfare? PhD: 3-4 years full-time; 5 years part-time; IPhD: 5 years full-time; MSc (Research): 1 year
-
, and how these molecules interact within cells to form complex functional networks. We are also working towards applications of our knowledge to address important real-world problems. PhD: 3-4 years full
-
and training. PhD: 3-4 years full-time; 5 years part-time; IPhD: 5 years full-time; MSc (Research): 1 year full-time; 2 year part-time; Apply now Research projects Research projects Self-funded projects
-
systems to the brain imaging of human behaviour and cognition as well as social level investigations. PhD: 3-4 years full-time; 5 years part-time; MD (Doctor of Medicine): 2 years full-time; 4 years part